financetom
Business
financetom
/
Business
/
Global EV sales up 21% in July as China records biggest jump of 2024, Rho Motion says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global EV sales up 21% in July as China records biggest jump of 2024, Rho Motion says
Aug 12, 2024 4:23 PM

(Reuters) - Global sales of fully electric and plug-in hybrid vehicles rose by a yearly 21% in July, thanks to China's strongest growth this year and despite dropping demand in Europe, market research firm Rho Motion said Monday.

In the European Union MG Motor, owned by China's SAIC Motor Corp, expects to be hit hardest by provisional tariffs imposed on EVs imported from China, Rho Motion data manager Charles Lester told Reuters.

The impact of the tariffs should be smaller on Tesla, which can produce in its Berlin factory, and Chinese EV giant BYD, whose presence in Europe remains small, Lester said.

BY THE NUMBERS

EVs - whether fully electric (BEV) or plug-in hybrids (PHEVs) - sold worldwide were at 1.35 million in July, of which 0.88 million were in China, where they were up 31% year-on-year, the data showed.

PHEVs sold in China in the first seven months of 2024 were up 70% from last year.

BYD, China's and the world's biggest EV maker, reported in the same period increases of 13% and 44% in its global BEV and PHEV sales, respectively.

In Europe, monthly sales were down 7.8% in July, to year-to-date figures in line with 2023. In the seven months to July, they dropped by 12% in Germany, the EU's biggest EV market.

In the United States and Canada, EV sales were up 7.1% in July.

KEY QUOTES

"BYD continued to have record sales of plug-in hybrids again this month, which is a key contributor as they have a large volume of vehicles that they sell", Lester told Reuters.

Range extender vehicles, battery-powered hybrid cars that recharge with an on-board generator, are also selling in large numbers, Lester said.

CONTEXT

The European Union imposed in July provisional tariffs on imports of electric cars made in China. BYD faces duties of 17.4%, Geely 19.9% and SAIC 37.6%, the EU said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Investment firm Kimmeridge buys 90% stake in Commonwealth LNG
Investment firm Kimmeridge buys 90% stake in Commonwealth LNG
Jun 25, 2024
HOUSTON, June 25 (Reuters) - Private equity firm Kimmeridge, through its subsidiary Kimmeridge Texas Gas, has acquired a 90% stake in proposed U.S. liquefied natural gas export project Commonwealth LNG, it said on Tuesday. The investment will allow the project to move ahead, the companies said. The sum paid for the controlling interest was not disclosed. Kimmeridge appointed former BP...
Atlassian Insider Sold Shares Worth $1,303,073, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,303,073, According to a Recent SEC Filing
Jun 25, 2024
04:23 PM EDT, 06/25/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-CEO, Co-Founder, on June 24, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,303,073. Following the Form 4 filing with the SEC, Farquhar has control over a total of 31,792 shares of the company, with 31,792 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024005288/xslF345X03/primarydocument.xml ...
Allakos Reports 'Positive' Results From Phase 1 Trial of Antibody That Inhibits Mast Cells
Allakos Reports 'Positive' Results From Phase 1 Trial of Antibody That Inhibits Mast Cells
Jun 25, 2024
04:21 PM EDT, 06/25/2024 (MT Newswires) -- Allakos ( ALLK ) reported positive results late Tuesday from its single and multiple ascending phase 1 study of intravenous AK006, a monoclonal antibody that selectively inhibits mast cells, in healthy volunteers. The company said inappropriate activation of mast cells is a pathogenic driver of multiple diseases, including chronic spontaneous urticaria, food allergy,...
Atlassian Insider Sold Shares Worth $1,303,074, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,303,074, According to a Recent SEC Filing
Jun 25, 2024
04:23 PM EDT, 06/25/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on June 24, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,303,074. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 31,792 shares of the company, with 31,792 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024005289/xslF345X03/primarydocument.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved